US 12,011,350 B2
Rapid implant prosthetic heart valve system
Rafael Pintor, Mission Viejo, CA (US); Mark Chau, Laguna Hills, CA (US); Travis Zenyo Oba, Yorba Linda, CA (US); August R. Yambao, Temecula, CA (US); Louis A. Campbell, Santa Ana, CA (US); Tammy Huntley, Lake Forest, CA (US); Qinggang Zeng, Mission Viejo, CA (US); Carey L Cristea, Lake Forest, CA (US); and Faisal Kalam, Corona, CA (US)
Assigned to EDWARDS LIFESCIENCES CORPORATION, Irvine, CA (US)
Filed by Edwards Lifesciences Corporation, Irvine, CA (US)
Filed on Nov. 17, 2022, as Appl. No. 18/056,691.
Application 18/056,691 is a division of application No. 17/067,618, filed on Oct. 9, 2020, granted, now 11,504,232.
Application 14/684,267 is a division of application No. 13/660,780, filed on Oct. 25, 2012, granted, now 9,005,278, issued on Apr. 14, 2015.
Application 17/067,618 is a continuation of application No. 16/248,706, filed on Jan. 15, 2019, granted, now 10,799,346, issued on Oct. 13, 2020.
Application 16/248,706 is a continuation of application No. 15/423,378, filed on Feb. 2, 2017, granted, now 10,182,909, issued on Jan. 22, 2019.
Application 15/423,378 is a continuation of application No. 14/684,267, filed on Apr. 10, 2015, granted, now 9,561,100, issued on Feb. 7, 2017.
Application 13/660,780 is a continuation of application No. 12/635,471, filed on Dec. 10, 2009, granted, now 8,308,798.
Claims priority of provisional application 61/139,398, filed on Dec. 19, 2008.
Prior Publication US 2023/0084393 A1, Mar. 16, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 2/24 (2006.01)
CPC A61F 2/2418 (2013.01) [A61F 2/2409 (2013.01); A61F 2/243 (2013.01); A61F 2/2433 (2013.01); A61F 2220/0016 (2013.01); A61F 2220/0025 (2013.01); A61F 2220/005 (2013.01); A61F 2220/0075 (2013.01); A61F 2220/0083 (2013.01); A61F 2230/0054 (2013.01); A61F 2230/0067 (2013.01); A61F 2230/0069 (2013.01); A61F 2230/0078 (2013.01); A61F 2250/006 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A prosthetic heart valve, comprising:
a non-expandable, non-collapsible prosthetic valve defining a flow orifice therethrough comprising a non-expandable, non-collapsible rigid component supporting blood flow-occluding leaflets, and
a self-expandable coupling stent having an outflow or proximal end defined by a proximal ring in contact with and sutured to a distal end of the rigid component, the proximal ring being configured to have a variable circumference enabling expansion, the coupling stent extending from the rigid component in a distal direction, the coupling stent having a contracted state for delivery to an implant position and an expanded state where a distal end thereof is configured for outward contact with a surrounding heart valve annulus.